These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17319485)
1. Renal effects of opioid exposure: considerations for therapeutic use. Gupta K; Weber ML J Opioid Manag; 2006; 2(4):236-40. PubMed ID: 17319485 [TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
6. Responsible prescribing of opioids for the management of chronic pain. Nicholson B Drugs; 2003; 63(1):17-32. PubMed ID: 12487620 [TBL] [Abstract][Full Text] [Related]
7. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics. Solhaug V; Molden E Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049 [TBL] [Abstract][Full Text] [Related]
8. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Candiotti KA; Gitlin MC Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361 [TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of opioid-induced hyperalgesia. Lee M; Silverman SM; Hansen H; Patel VB; Manchikanti L Pain Physician; 2011; 14(2):145-61. PubMed ID: 21412369 [TBL] [Abstract][Full Text] [Related]
10. Considerations in addressing the opioid epidemic and chronic pain within the USA. Marshall B; Bland MK; Hulla R; Gatchel RJ Pain Manag; 2019 Mar; 9(2):131-138. PubMed ID: 30806566 [TBL] [Abstract][Full Text] [Related]
11. [Pain and opioids]. Murányi M; Radák Z Orv Hetil; 2008 Dec; 149(50):2363-70. PubMed ID: 19073443 [TBL] [Abstract][Full Text] [Related]
12. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine. Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Manchikanti L; Manchikanti KN; Pampati V; Cash KA Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308 [TBL] [Abstract][Full Text] [Related]
14. Opioid and adjuvant analgesics: compared and contrasted. Khan MI; Walsh D; Brito-Dellan N Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486 [TBL] [Abstract][Full Text] [Related]
15. Rethinking the role of opioids in the outpatient management of chronic nonmalignant pain. Provenzano DA; Viscusi ER Curr Med Res Opin; 2014 Oct; 30(10):2051-62. PubMed ID: 24809728 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte opioid receptors as innovative biomarkers of osteoarthritic pain, for the assessment and risk management of opioid tailored therapy, before hip surgery, to prevent chronic pain and opioid tolerance/addiction development: OpMarkArt (Opioids-Markers-Arthroprosthesis) study protocol for a randomized controlled trial. Malafoglia V; Celi M; Muscoli C; Ilari S; Lauro F; Giancotti LA; Morabito C; Feola M; Tarantino U; Raffaeli W Trials; 2017 Dec; 18(1):605. PubMed ID: 29258584 [TBL] [Abstract][Full Text] [Related]
17. Abuse-deterrent opioids: an update on current approaches and considerations. Pergolizzi JV; Raffa RB; Taylor R; Vacalis S Curr Med Res Opin; 2018 Apr; 34(4):711-723. PubMed ID: 29262730 [TBL] [Abstract][Full Text] [Related]